Cancer Health Treatment Update Does Chemotherapy Work Better in the Afternoon? Women with lymphoma who received treatment in the afternoon had lower relapse and mortality rates than those treated earlier in the day. “Terrible Crisis” as Shortage of Bladder Cancer Therapy Persists Since 2020, there has been a nationwide shortage of the bladder cancer therapy Bacillus Calmette Guérin (BCG). Here’s why. Early-Age Onset Colorectal Cancer: Health Disparities in the Black Population Black people are more likely to be diagnosed with CRC at a younger age and a more advanced stage than white people. Bare Your Butt for Colorectal Cancer Awareness Month The #MarchYourButt campaign wants to destigmatize our behinds and promote colorectal cancer screening. Advertisement Cancer Health Winter 2023 Check out our latest print edition! Cancer Health now offers individual newsletters for people interested in specific cancer types. Get the latest cancer news tailored to your needs and interests delivered to your inbox. To update your preferences and start getting cancer-specific newsletters, please visit your personal preferences page. Latinos, Blacks More Likely to Have Long COVID Symptoms Researchers encourage additional studies to determine why Black and Latino people experience long COVID symptoms more than white people. More News About COVID-19 See all Cancer Health's coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Newsfeed A Slew of State Proposals Shows the Threat of 'Forever Chemicals' Bare Your Butt for Colorectal Cancer Awareness Month “Terrible Crisis” as Shortage of Bladder Cancer Therapy Persists What Do Cancer Patients and Survivors Look for in Health Insurance Plans? Blog: National Cancer Institute Tukysa and Herceptin Combo OK’d for HER2-Positive Colorectal Cancer Studies Test CAR T-Cell Therapies Designed to Overcome Key Limitations Help Desk for Oncologists Treating a Rare Leukemia Pays Big Dividends Brukinsa’s Approval Improves Targeted Treatment for Leukemia Newsfeed A Slew of State Proposals Shows the Threat of 'Forever Chemicals' Bare Your Butt for Colorectal Cancer Awareness Month “Terrible Crisis” as Shortage of Bladder Cancer Therapy Persists What Do Cancer Patients and Survivors Look for in Health Insurance Plans? Blog: National Cancer Institute Tukysa and Herceptin Combo OK’d for HER2-Positive Colorectal Cancer Studies Test CAR T-Cell Therapies Designed to Overcome Key Limitations Help Desk for Oncologists Treating a Rare Leukemia Pays Big Dividends Brukinsa’s Approval Improves Targeted Treatment for Leukemia

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: